Crinetics Pharmaceuticals...

NASDAQ: CRNX · Real-Time Price · USD
30.23
0.54 (1.82%)
At close: Aug 15, 2025, 1:20 PM

Crinetics Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
264.55M 54.9M 32.67M 200.69M
Short-Term Investments
1.09B 503.66M 301.75M 133.01M
Long-Term Investments
800K 1.77M 1.97M 1.01M
Other Long-Term Assets
2.83M 2M 37K 568K
Receivables
8.47M 9.35M 2.42M 2.03M
Inventory
n/a n/a n/a -2.03M
Other Current Assets
1.71M 1.58M 4.83M 2.03M
Total Current Assets
1.38B 574.15M 345.18M 344.72M
Property-Plant & Equipment
55.58M 57.43M 4.99M 4.72M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
59.2M 61.2M 6.99M 6.29M
Total Assets
1.43B 635.35M 352.18M 351.01M
Account Payables
5.85M 6.55M 6.88M 3.42M
Deferred Revenue
2.18M 2.06M 2.24M -939K
Short-Term Debt
7.15M 4.17M 1.05M 939K
Other Current Liabilities
-7.14M 12.47M 7.42M n/a
Total Current Liabilities
59.68M 43.94M 27.72M 15.99M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
829K n/a 6.1M 2K
Total Long-Term Liabilities
50.1M 52.3M 8.13M 3.08M
Total Liabilities
109.79M 96.25M 35.85M 19.07M
Total Debt
51.72M 51.73M 3.08M 3.07M
Common Stock
2.28B 1.19B 759.43M 607.58M
Retained Earnings
-952.11M -653.7M -439.17M -275.25M
Comprehensive Income
963K 977K -3.93M -382K
Shareholders Equity
1.32B 539.11M 316.33M 331.94M
Total Investments
1.09B 505.43M 301.75M 134.02M